Sysmex said Friday it has obtained marketing approval in Japan for the distribution of BGI Genomics' 2019-nCoV Fluorescence Detection Real-Time RT-PCR Kit.

Fosun Pharmaceutical said on Thursday that its Fosun Long March Medical Science subsidiary has received emergency approval from China's National Medical Products Administration for a SARS-CoV-2 detection kit.

PerkinElmer said after the close of the market on Tuesday that the US Food and Drug Administration has issued Emergency Use Authorization for the firm's coronavirus RT-PCR test.

Mesa Biotech said on Tuesday that it has received Emergency Use Authorization from the US Food and Drug Administration for its Accula SARS-CoV-2 test.

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

UK Company Starts Trials of Inhaled Formulation for COVID-19

Defects on the glass surface are a major cause of occasional breakage of the primary packaging container during fill and finish or transport.

Following reports that hydroxychloroquine and chloroquine are under evaluation in clinical trials as a potential treatment of COVID-19, drug companies are donating doses and planning for ramping up supply.

FDA, EMA Collaborate on SARS-CoV-2 Vaccine Development

On March 23, 2020, Eli Lilly and Company provided an update on the company's clinical trial activities in light of the COVID-19 pandemic.

BioMérieux said on Tuesday that an assay developed by its subsidiary BioFire Defense to rapidly detect COVID-19

Japanese Regulators Approve Merck KGaA MET Inhibitor With ArcherDx CDx

The US Food and Drug Administration on Friday warned consumers to watch out for companies marketing unproven products for diagnosing, preventing, or treating COVID-19.

While many in the US and Europe have only recently come to understand the scope and severity of the SARS-CoV-2 pandemic, a handful of proteomics labs have been studying the virus since the beginning of the year.

A new UK-based research consortium is betting that sequencing the virus that causes COVID-19 can provide policymakers with a clearer picture of the spread of the epidemic across the country as diagnostic testing remains limited.